サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：脳炎治療市場：タイプ別、治療法別、症状別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1335280

脳炎治療市場：タイプ別、治療法別、症状別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Encephalitis Treatment Market with COVID-19 Impact Analysis, By Type, By Treatment, By Symptoms, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 269 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳炎治療市場：タイプ別、治療法別、症状別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

脳炎治療市場規模は2022年に201億890万米ドルとなり、2023年から2030年にかけてCAGR 5.3%で拡大

脳炎治療市場-市場力学：

  • 脳炎有病率の増加が市場成長を促進
  • 脳炎患者の増加が脳炎治療薬の世界市場を活性化すると予測されます。時間とともに悪化する長引く脳炎の一種はCFEと呼ばれます。脳の大脳半球が炎症の影響を受けることが多く、焦点発作を繰り返すなど重度のてんかん活動を引き起こします。脳の炎症が続くため、CFEの患者は、回復不可能な脳の損傷、運動能力の低下、精神的な悪化をきたす可能性があります。この病気は主に2歳から10歳の子供が罹患し、世界中で200-500例しか記録されていないです。したがって、前述の事実は予測期間中の市場成長を支えています。

脳炎治療市場-セグメンテーション分析：

  • 世界の脳炎治療市場は、タイプ、治療法、症状、エンドユーザー、地域によって区分されます。
  • タイプに基づき、市場は一次と二次に二分されます。予測期間中、一次市場が市場を独占すると予測されます。このセグメントの成長は、二次性脳炎よりも一次性脳炎の有病率が増加していることに起因しています。一次性脳炎とは、体の他の部位に先行感染がなく、感染因子によって直接脳に炎症が引き起こされるケースを指します。一次性脳炎を引き起こす一般的な感染因子には、単純ヘルペスウイルス（HSV）、ウエストナイルウイルス（WNV）、エンテロウイルスなどのウイルスがあります。HSV脳炎は、一次性脳炎の中でも最も重症のもの1つで、早急な治療が必要です。HSV脳炎は一次性脳炎の中でも最も重篤なものひとつであり、早急な治療が必要です。そのため、セグメント拡大の原動力となっています。

脳炎治療市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分割されます。予測期間中、北米が市場を独占すると見られています。脳炎患者は北米全域で発生しており、地域や脳炎のタイプ（ウイルス性、自己免疫性など）によって有病率は異なります。単純ヘルペス脳炎などのウイルス性脳炎は、米国における散発性脳炎の主要な原因の1つであると報告されています。さらに、北米、特に米国は脳炎の研究と臨床試験の最前線にあります。多くの学術機関、製薬会社、研究機関が脳炎の病因の研究、新たな治療法の特定、潜在的なワクチンの探索に積極的に取り組んでいます。このため、同地域の市場成長を牽引するものと期待されています。

脳炎治療市場-競合情勢：

世界の脳炎治療市場の主要企業は、製品ラインナップの多様化を図るため、研究開発活動を強化しています。さらに、これらの市場参入企業は、成長を促進する戦略的提携やパートナーシップを利用しています。同市場に参入している主要企業には、アラガン社、メルク社、ファイザー社、グラクソ・スミスクライン社、メリンタ・セラピューティクス社、バシリア・ファーマスーティカ社、アボット社、F.ホフマン・ラ・ロシュ社、マイラン社、テバ・ファーマシューティカル・インダストリーズ社、サノフィ社、ノバルティス社、ノバルティスAG社、サノフィ社、ノバルティスAG社が含まれます、サノフィ、ノバルティスAG、バイエルAG、サン・ファーマシューティカル・インダストリーズ・リミテッド、オーロビンド・ファーマ、ルパン、アッヴィ・インク、カンバーランド・ファーマシューティカルズ・インク、イーライリリー・アンド・カンパニー、エンド・インターナショナル・ピーエルシー、ザイダス・カディラ、フレゼニウス・カビAG。

目次

第1章 脳炎治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 脳炎治療の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 脳炎治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 脳炎治療市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 脳炎治療市場情勢

  • 脳炎治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 脳炎治療市場- 種類別

  • 概要
    • タイプ別セグメントシェア分析
    • 原発性脳炎
    • 続発性脳炎

第8章 脳炎治療市場- 治療別

  • 概要
    • 治療別セグメントシェア分析
    • 抗ウイルス剤
    • ステロイド注射
    • 抗生物質
    • 免疫グロブリン療法
    • 血漿交換
    • その他

第9章 脳炎治療市場- 症状別

  • 概要
    • 症状別のセグメントシェア分析
    • 熱
    • 眠気
    • 頭痛
    • 性格の変化
    • イライラ
    • 混乱
    • 弱点
    • 発作
    • その他

第10章 脳炎治療市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 診療所
    • 病院
    • その他

第11章 脳炎治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 脳炎治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Allergan
    • Merck &Co., Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Melinta Therapeutics LLC
    • Basilea Pharmaceutica Ltd.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Novartis AG
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • AbbVie Inc.
    • Cumberland Pharmaceuticals Inc.
    • Eli Lilly and Company
    • Endo International plc
    • Zydus Cadila
    • Fresenius Kabi AG

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Encephalitis Treatment Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Encephalitis Treatment Market, by Type 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Encephalitis Treatment Market, by Treatment 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Symptoms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Symptoms
  • TABLE Global Encephalitis Treatment Market, by Symptoms 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Encephalitis Treatment Market, by End User 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Encephalitis Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Encephalitis Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022 & 2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Symptoms segment market share analysis, 2022 & 2030
  • FIGURE Symptoms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Europe Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Latin America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Encephalitis Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Germany Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE India Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Brazil Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1573

REPORT HIGHLIGHT

Encephalitis Treatment Market size was valued at USD 20,108.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.

An infection or an inflammatory reaction that affects the brain's active tissues might result in encephalitis. The goal of encephalitis treatment is to reduce head swelling and avert complications. Intravenous antibiotics can be administered to treat encephalitis if a bacterial infection is to blame. Herpes-related encephalitis is treated with supportive care and intravenous antiviral drugs including acyclovir. The patient should also be kept hydrated, their temperature should be reduced, and seizures should be treated, and any pressure in their skull should be eased.

Encephalitis Treatment Market- Market Dynamics:

  • Growing prevalence of encephalitis to propel market growth.
  • An increase in encephalitis cases is anticipated to fuel the global market for encephalitis treatments. A type of lingering brain inflammation that becomes worse over time is called CFE. The cerebral hemisphere of the brain is often affected by inflammation, which causes severe epileptic activity such as recurring focal seizures. Because of the ongoing brain inflammation, people with CFE may have irreparable brain damage, loss of motor abilities, and mental deterioration. The sickness mostly affects children between the ages of 2 and 10, and there have only been 200-500 recorded cases worldwide. Thereby, the aforementioned facts support the market growth during the forecast period.

Encephalitis Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Encephalitis Treatment market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
  • The Encephalitis Treatment industry is projected to grow at a significant rate owing to the high prevalence of encephalitis across the globe
  • Based on type segmentation, the primary segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Encephalitis Treatment Market- Segmentation Analysis:

  • The Global Encephalitis Treatment Market is segmented based on type, treatment, symptoms, end user, and Region.
  • Based on type, the market is bifurcated into primary and secondary. The primary segment is expected to dominate the market during the forecast period. The segment growth is attributed to the growing prevalence of primary encephalitis over secondary encephalitis. Primary encephalitis refers to cases where the inflammation of the brain is directly caused by an infectious agent, without any prior infection in other parts of the body. Common infectious agents causing primary encephalitis include viruses like herpes simplex virus (HSV), West Nile virus (WNV), and enteroviruses. HSV encephalitis is one of the most severe forms of primary encephalitis and requires immediate medical attention. It can lead to significant brain damage and neurological complications if not treated promptly. Thereby, driving the segment expansion.

Encephalitis Treatment Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. Encephalitis cases occur throughout North America, with varying prevalence rates depending on the region and the type of encephalitis (e.g., viral, autoimmune). Viral encephalitis, such as herpes simplex encephalitis, has been reported to be one of the leading causes of sporadic encephalitis in the United States. Moreover, North America, particularly the United States, has been at the forefront of encephalitis research and clinical trials. Many academic institutions, pharmaceutical companies, and research organizations are actively involved in studying the pathogenesis of encephalitis, identifying new treatment modalities, and exploring potential vaccines. Thus, this is expected to drive the market growth in the region.

Encephalitis Treatment Market- Competitive Landscape:

Leading companies in the worldwide Encephalitis Treatment market are stepping up their R&D efforts to diversify their product offerings. Additionally, these market participants use strategic alliances and partnerships that promote growth. The key players operating in the market include Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Endo International plc, Zydus Cadila, and Fresenius Kabi AG.

Recent Developments:

In August 2021, the Tick-Borne Encephalitis (TBE) vaccine, known as TICOVAC, was approved by the United States Food and Drug Administration (USFDA). In the wild, it can generate TBE virus-neutralizing antibodies. Albumin, a component of human blood, is present in TICOVAC. Virus transmission and variant Creutzfeldt-Jakob disease (vCJD) transmission are extremely unlikely due to effective donor screening and product processing procedures.

Key features of the study:

  • This proposed research study on Encephalitis Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Encephalitis Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Encephalitis Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Encephalitis Treatment market
  • Impact of COVID-19 on Encephalitis Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Encephalitis Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Encephalitis Treatment market, we have also included competitive landscape and key innovator analysis for the Encephalitis Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Encephalitis Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Encephalitis Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENCEPHALITIS TREATMENT MARKET KEY PLAYERS

  • Allergan
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Melinta Therapeutics LLC
  • Basilea Pharmaceutica Ltd.
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • AbbVie Inc.
  • Cumberland Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Endo International plc
  • Zydus Cadila
  • Fresenius Kabi AG

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TYPE

  • Primary Encephalitis
  • Secondary Encephalitis

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TREATMENT

  • Antiviral Agents
  • Steroid Injection
  • Antibiotics
  • Immunoglobulin Therapy
  • Plasmapheresis
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY SYMPTOMS

  • Fever
  • Drowsiness
  • Headaches
  • Personality Changes
  • Irritability
  • Confusion
  • Weakness
  • Seizures
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY END USER

  • Clinic
  • Hospital
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Encephalitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Encephalitis Treatment Market Snippet by Type
    • 2.1.2. Encephalitis Treatment Market Snippet by Treatment
    • 2.1.3. Encephalitis Treatment Market Snippet by Symptoms
    • 2.1.4. Encephalitis Treatment Market Snippet by End User
    • 2.1.5. Encephalitis Treatment Market Snippet by Country
    • 2.1.6. Encephalitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Encephalitis Treatment Key Market Trends

  • 3.1. Encephalitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Encephalitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Encephalitis Treatment Market Opportunities
  • 3.4. Encephalitis Treatment Market Future Trends

4. Encephalitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Encephalitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Encephalitis Treatment Market Landscape

  • 6.1. Encephalitis Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Encephalitis Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Primary Encephalitis
    • 7.1.3. Secondary Encephalitis

8. Encephalitis Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Antiviral Agents
    • 8.1.3. Steroid Injection
    • 8.1.4. Antibiotics
    • 8.1.5. Immunoglobulin Therapy
    • 8.1.6. Plasmapheresis
    • 8.1.7. Others

9. Encephalitis Treatment Market - By Symptoms

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Symptoms, 2022 & 2030 (%)
    • 9.1.2. Fever
    • 9.1.3. Drowsiness
    • 9.1.4. Headaches
    • 9.1.5. Personality Changes
    • 9.1.6. Irritability
    • 9.1.7. Confusion
    • 9.1.8. Weakness
    • 9.1.9. Seizures
    • 9.1.10. Others

10. Encephalitis Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Clinic
    • 10.1.3. Hospital
    • 10.1.4. Others

11. Encephalitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Encephalitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Encephalitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Encephalitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Encephalitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Encephalitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Encephalitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allergan
    • 12.2.2. Merck & Co., Inc.
    • 12.2.3. Pfizer Inc.
    • 12.2.4. GlaxoSmithKline plc
    • 12.2.5. Melinta Therapeutics LLC
    • 12.2.6. Basilea Pharmaceutica Ltd.
    • 12.2.7. Abbott
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Mylan N.V.
    • 12.2.10. Teva Pharmaceutical Industries Ltd.
    • 12.2.11. Sanofi
    • 12.2.12. Novartis AG
    • 12.2.13. Bayer AG
    • 12.2.14. Sun Pharmaceutical Industries Ltd.
    • 12.2.15. Aurobindo Pharma
    • 12.2.16. Lupin
    • 12.2.17. AbbVie Inc.
    • 12.2.18. Cumberland Pharmaceuticals Inc.
    • 12.2.19. Eli Lilly and Company
    • 12.2.20. Endo International plc
    • 12.2.21. Zydus Cadila
    • 12.2.22. Fresenius Kabi AG

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us